Contract 75N93020C00004
Meabco Inc · Department Of Health And Human Services · April 30, 2020
Meabco Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on April 30, 2020 for $6.43 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Chicago, IL. It was awarded under full and open competition. The contract has been modified 20 times since the base award It uses cost-plus contract pricing. The most recent modification was on January 16, 2025.
Contract details
- PIID
- 75N93020C00004
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Chicago, IL
- First action
- April 30, 2020
- Latest action
- January 16, 2025
Description
ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2
Modification timeline
-
January 16, 2025Mod P00020$-2
-
August 28, 2024Mod P00019$0
-
February 26, 2024Mod P00018$0
-
September 5, 2023Mod P00017$0
-
April 27, 2023Mod P00016$0
-
February 28, 2023Mod P00015$0
-
February 2, 2023Mod P00014IPP: ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2$0
-
November 15, 2022Mod P00013IPP: ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2$0
-
August 26, 2022Mod P00012$39.0K
-
July 19, 2022Mod P00011$27.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93020C00004?
Contract 75N93020C00004 is a federal contract awarded to Meabco Inc by Department Of Health And Human Services on April 30, 2020 for $6.43 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 20 times since the base award.
Who won contract 75N93020C00004?
Meabco Inc won contract 75N93020C00004 from Department Of Health And Human Services.
How much is contract 75N93020C00004 worth?
Contract 75N93020C00004 has obligated $6.43 million to date.